current
refer
diagnosi
base
detect
rna
extract
use
onestep
retrotranscript
quantit
pcr
rtqpcr
base
urgent
need
highthroughput
screen
test
perform
three
altern
simpl
afford
protocol
rapidli
detect
overcom
long
tediou
rna
extract
step
although
averag
increas
cycl
compar
standard
test
rna
extract
show
rtqpcr
yield
consist
result
nasopharyng
swab
sampl
subject
direct
c
incub
min
find
provid
viabl
option
overcom
suppli
chain
issu
help
increas
throughput
diagnost
test
use
qpcr
devic
therebi
complement
standard
test
ongo
coronaviru
diseas
pandem
due
sever
acut
respiratori
syndrom
coronaviru
worldwid
infect
http
impos
unexpect
high
burden
health
care
system
worldwid
lead
increas
demand
daili
diagnost
screen
current
standard
assay
diagnosi
base
extract
rna
respiratori
sampl
especi
nasopharyng
swab
viral
transport
media
vtm
subsequ
onestep
revers
transcript
realtim
quantit
pcr
rtqpcr
target
one
sever
sequenc
corman
et
al
howev
standard
procedur
usual
take
h
consid
manual
intervent
risk
reagent
shortag
major
kit
supplier
particularli
rna
extract
step
besid
common
hospit
practic
reli
liquidhandl
robot
rna
extract
add
anoth
bottleneck
nowaday
given
larg
number
popul
screen
aim
simplifi
current
diagnost
standard
overcom
rna
extract
step
test
three
simpl
approach
base
direct
nasopharyng
swab
vtm
heat
rtqpcr
directli
without
addit
direct
b
formamideedta
fae
buffer
shedlovskiy
shcherbik
pestov
c
rnasnap
tm
buffer
stead
et
al
refer
compar
result
obtain
use
standard
rna
extract
protocol
sampl
studi
conduct
univers
hospit
nuestra
de
candelaria
santa
cruz
de
tenerif
spain
march
institut
review
board
approv
studi
ethic
approv
number
sampl
select
nasopharyng
swab
four
patient
four
neg
control
collect
ml
volum
vtm
deltalab
sampl
manipul
perform
biosafeti
class
ii
cabinet
telstar
bioiia
diagnosi
infect
conduct
vtm
standard
rna
extract
use
magcor
viral
nucleic
acid
extract
kit
rbc
bioscienc
magcor
liquid
handler
rbc
bioscienc
last
approxim
h
nuclisen
easymag
kit
emag
liquid
handler
last
approxim
h
min
onestep
rtqpcr
use
modular
sar
wuhan
cov
egen
kit
roch
commerci
mix
supplement
primer
probe
detect
human
actin
actb
gene
express
serv
intern
control
reaction
describ
elsewher
fenollar
et
al
tabl
experi
includ
nontempl
control
posit
control
egen
amplif
kit
sarbecoviru
ivrna
control
roch
rtqpcr
perform
final
volum
reaction
sampl
use
touch
realtim
pcr
detect
system
biorad
follow
specif
thermal
cycl
perform
c
min
rt
step
follow
amplif
step
initi
denatur
c
min
cycl
c
sec
c
sec
c
sec
final
cool
step
c
sec
also
includ
thermal
cycl
took
h
min
total
altern
sampl
treatment
fresh
fae
rnasnap
tm
buffer
prepar
molecular
biolog
grade
reagent
follow
describ
condit
stead
et
al
shedlovskiy
shcherbik
pestov
aliquot
vtm
sampl
mix
buffer
use
vigor
vortex
heat
c
min
note
rnasnap
tm
procedur
origin
describ
use
c
min
parallel
aliquot
sampl
also
heat
c
min
rtqpcr
perform
temperaturetr
sampl
aliquot
treatment
final
volum
use
condit
describ
standard
diagnosi
infect
sampl
treatment
select
nasopharyng
swab
sampl
independ
donor
diagnosi
infect
avail
follow
method
indic
posit
neg
experi
also
includ
nontempl
control
posit
control
egen
amplif
sampl
subject
treatment
provid
result
smallest
cycl
threshold
ct
deviat
standard
protocol
exploratori
stage
experi
blind
diagnosi
assign
result
confus
matrix
use
obtain
sensit
specif
accuraci
altern
sampl
treatment
compar
assay
base
standard
rna
extract
ensur
nontempl
control
amplifi
protocol
actb
similarli
posit
control
egen
amplif
yield
posit
result
rtqpcr
experi
three
altern
sampl
treatment
protocol
use
specif
highli
sensit
probe
coronaviru
egen
amplif
lead
optim
result
therefor
rational
first
test
design
follow
assay
corman
et
al
note
envelop
small
membran
protein
e
requir
produc
structur
complet
viral
particl
togeth
three
major
structur
protein
spike
nucleocapsid
n
membran
protein
mortola
roy
master
wang
sampl
gave
posit
result
intern
human
actb
ct
egen
amplif
standard
rna
extract
indic
two
posit
case
low
ct
two
larg
valu
ct
tabl
four
posit
case
amplifi
three
treatment
none
neg
sampl
amplifi
egen
treatment
although
ct
valu
egen
posit
sampl
concord
within
sampl
among
treatment
observ
displac
ct
posit
sampl
use
three
altern
treatment
compar
standard
rna
extract
tabl
compar
standard
rna
extract
observ
egen
averag
sd
increas
ct
direct
rnasnap
tm
fae
treatment
respect
figur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
base
result
assay
vtm
sampl
independ
donor
use
direct
method
procedur
previou
stage
reaction
nontempl
control
amplifi
posit
control
egen
amplif
yield
posit
result
verifi
sampl
gave
posit
result
intern
human
actb
averag
ct
although
amplif
ct
averag
slightli
larger
obtain
standard
rna
extract
method
sampl
averag
ct
posit
vtm
sampl
five
yield
amplif
egen
direct
treatment
regard
actb
gene
amplif
result
extract
rna
five
sampl
observ
signific
differ
compar
posit
sampl
averag
ct
respect
howev
ct
valu
egen
significantli
larger
averag
ct
respect
therefor
consid
five
sampl
fals
neg
correspond
fals
neg
rate
direct
treatment
confid
interv
ci
consid
sampl
posit
two
method
averag
increas
egen
ct
direct
method
compar
obtain
regular
rna
extract
none
neg
vtm
sampl
classifi
posit
direct
treatment
therefor
direct
method
yield
sensit
specif
accuraci
ci
ci
respect
three
heat
treatment
sampl
direct
use
subsequ
detect
demonstr
posit
amplif
egen
direct
method
provid
best
result
highli
consist
infect
diagnosi
base
standard
rna
extract
nearli
half
time
figur
warn
observ
amplif
target
altern
kit
sampl
test
use
direct
method
ie
modular
sar
wuhan
cov
ngene
rdrp
kit
roch
shown
like
reduc
sensit
compar
calcul
egen
perform
altern
simpl
afford
protocol
help
acceler
infect
diagnosi
caution
studi
done
limit
number
sampl
amplif
close
monitor
avoid
increas
fals
neg
standard
diagnosi
base
rna
extract
xie
et
al
given
compar
environment
stabil
close
relat
human
coronaviru
van
doremalen
et
al
evid
suggest
lose
infect
c
within
short
period
time
geller
varbanov
duval
postul
direct
protocol
may
also
help
control
infect
manipul
sampl
infect
diagnosi
feel
result
provid
viabl
option
overcom
suppli
chain
issu
help
increas
throughput
infect
diagnosi
therebi
allow
afford
fast
sensit
laboratori
test
studi
support
cabildo
insular
de
tenerif
agreement
instituto
de
renov
iter
strengthen
scientif
technolog
educ
train
research
develop
innov
genom
person
medicin
biotechnolog
ministerio
de
ciencia
cofund
european
region
develop
fund
erdf
lab
facil
cofund
erdf
cajacanaria
spanish
hivaid
research
network
risret
cofund
instituto
de
salud
carlo
iii
erdf
tabl
tabl
oligonucleotid
sequenc
use
detect
actb
gene
express
intern
reaction
control
detect
nucleotid
sequenc
label
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
figur
schemat
diagram
standard
rna
extractionbas
protocol
compar
altern
fast
protocol
b
timesav
estim
rtqpcrbase
test
indic
time
taken
conserv
estim
depend
personnel
skill
number
sampl
assess
experi
ct
cycl
threshold
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
